The RITA-MI2 project First Annual Meeting took place on Tuesday 21st June 2022, on-line. 🖥📆📊 23 project members working for one of the 13 project partners gathered one afternoon to present and discuss about the project’s first year and the next steps to be taken...
The RITA-MI2 trial is listed on clinicaltrials.gov, under registration number NCT05211401. Study Description Brief Summary The main objective is to compare the effect of a single injection of two doses of rituximab versus placebo on 6 months left...
Project partners met on-line on the 23rd Sept 2021 for the project kick-off meeting. 🖥👩⚕️👨⚕️🏣🩺 It was the occasion to introduce the different team involved. PIs presented the different Workpackages (and their current status). A dedicated presentation regarding the...
